Cyberonics (NASDAQ:CYBX) will report earnings before markets open on Thursday, August 22nd. Cyberonics, Inc. designs, develops, and markets medical devices. The Company’s devices are used for the treatment of epilepsy and other debilitating neurological, psychiatric, and other disorders. Cyberonics’ NCP System is approved for sale in the United States, Europe, Canada, and other markets.
Here is your Cheat Sheet to Cyberonics Earnings:
Earnings Expectations: Analysts expect earnings of $0.46 per share on revenues of $67.80 million. Currently, the company’s P/E ratio stands at 32.07.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.48 to a profit $0.49. For the current year, the average estimate is a profit of $1.98, which is better than the estimate ninety days ago.
Here’s how Cyberonics has been performing on an annual basis:
|Revenue ($) in millions||144||168||190||219||254|
|Diluted EPS ($)||0.97||2.67||1.64||1.27||1.66|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jul. 31, 2012||Oct. 31, 2012||Jan. 31, 2013||Apr. 30, 2013|
|Revenue ($) in millions||60.32||62.96||62.70||68.34|
|Diluted EPS ($)||0.29||0.48||0.47||0.41|
Cyberonics has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)